ArticleFrontiers in toxicology2026
Bridging gaps between scientific research and regulatory decision-making in Europe: roles of academia, risk assessors, and policymakers.
Article in Frontiers in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A gap between scientific research and regulatory frameworks continues to challenge the effective translation of science into policy and regulation. This commentary explores the disconnection between scientific research, regulatory agencies, and policymakers, highlighting the distinct yet interdependent roles they play. Researchers generate data, which is used by regulatory agencies for risk assessment, and these outcomes serve as the basis for policy development by policymakers. However, misalignments between these key stakeholders hinder effective integration, with consequences for advancing technological development. Additionally, it proposes a set of practical and strategic solutions that span academia, regulatory science, and policymaking to aid the effective integration of science into policy and regulation. Regulatory frameworks that encourage data harmonization, new options for validation, and accessibility are needed. Funding mechanisms that incentivize responsible and relevant research practices are also emphasized. Finally, the importance of open communication and targeted training for researchers and regulators to bridge knowledge gaps and build trust is also discussed. By addressing these issues, this manuscript aims to strengthen the synergy between scientific developments and regulation, advancing evidence-based policymaking. Enhancing robust, reliable and relevant science would improve regulatory decision-making processes, while also guiding researchers on responsible methodologies and setting standards for future research recommendations. The paper advocates for a collaborative approach to enhance the relevance and reliability of published research in guiding evidence-based regulation and policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.